Skip to main content
Top
Published in: Critical Care 2/2014

Open Access 01-04-2014 | Research

Multilevel competing risk models to evaluate the risk of nosocomial infection

Authors: Martin Wolkewitz, Ben S Cooper, Mercedes Palomar-Martinez, Francisco Alvarez-Lerma, Pedro Olaechea-Astigarraga, Adrian G Barnett, Stephan Harbarth, Martin Schumacher

Published in: Critical Care | Issue 2/2014

Login to get access

Abstract

Introduction

Risk factor analyses for nosocomial infections (NIs) are complex. First, due to competing events for NI, the association between risk factors of NI as measured using hazard rates may not coincide with the association using cumulative probability (risk). Second, patients from the same intensive care unit (ICU) who share the same environmental exposure are likely to be more similar with regard to risk factors predisposing to a NI than patients from different ICUs. We aimed to develop an analytical approach to account for both features and to use it to evaluate associations between patient- and ICU-level characteristics with both rates of NI and competing risks and with the cumulative probability of infection.

Methods

We considered a multicenter database of 159 intensive care units containing 109,216 admissions (813,739 admission-days) from the Spanish HELICS-ENVIN ICU network. We analyzed the data using two models: an etiologic model (rate based) and a predictive model (risk based). In both models, random effects (shared frailties) were introduced to assess heterogeneity. Death and discharge without NI are treated as competing events for NI.

Results

There was a large heterogeneity across ICUs in NI hazard rates, which remained after accounting for multilevel risk factors, meaning that there are remaining unobserved ICU-specific factors that influence NI occurrence. Heterogeneity across ICUs in terms of cumulative probability of NI was even more pronounced. Several risk factors had markedly different associations in the rate-based and risk-based models. For some, the associations differed in magnitude. For example, high Acute Physiology and Chronic Health Evaluation II (APACHE II) scores were associated with modest increases in the rate of nosocomial bacteremia, but large increases in the risk. Others differed in sign, for example respiratory vs cardiovascular diagnostic categories were associated with a reduced rate of nosocomial bacteremia, but an increased risk.

Conclusions

A combination of competing risks and multilevel models is required to understand direct and indirect risk factors for NI and distinguish patient-level from ICU-level factors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, Agodi A, Frank U, Mertens K, Schumacher M, Wolkewitz M: Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011, 11: 30-38. 10.1016/S1473-3099(10)70258-9CrossRefPubMed Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, Agodi A, Frank U, Mertens K, Schumacher M, Wolkewitz M: Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011, 11: 30-38. 10.1016/S1473-3099(10)70258-9CrossRefPubMed
2.
go back to reference Januel JM, Harbarth S, Allard R, Voirin N, Lepape A, Allaouchiche B, Guerin C, Lehot JJ, Robert MO, Fournier G, Jacques D, Chassard D, Gueugniaud PY, Artru F, Petit P, Robert D, Mohammedi I, Girard R, Cetre JC, Nicolle MC, Grando J, Fabry J, Vanhems P: Estimating attributable mortality due to nosocomial infections acquired in intensive care units. Infect Control Hosp Epidemiol 2010,31(4):388-394. 10.1086/650754CrossRefPubMed Januel JM, Harbarth S, Allard R, Voirin N, Lepape A, Allaouchiche B, Guerin C, Lehot JJ, Robert MO, Fournier G, Jacques D, Chassard D, Gueugniaud PY, Artru F, Petit P, Robert D, Mohammedi I, Girard R, Cetre JC, Nicolle MC, Grando J, Fabry J, Vanhems P: Estimating attributable mortality due to nosocomial infections acquired in intensive care units. Infect Control Hosp Epidemiol 2010,31(4):388-394. 10.1086/650754CrossRefPubMed
3.
go back to reference Harbarth S, Sax H, Gastmeier P: The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003,54(4):258-266. 10.1016/S0195-6701(03)00150-6CrossRefPubMed Harbarth S, Sax H, Gastmeier P: The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003,54(4):258-266. 10.1016/S0195-6701(03)00150-6CrossRefPubMed
4.
go back to reference Roux AVD, Aiello AE: Multilevel analysis of infectious diseases. J Infect Dis 2005,191(Supplement 1):S25-S33. Roux AVD, Aiello AE: Multilevel analysis of infectious diseases. J Infect Dis 2005,191(Supplement 1):S25-S33.
5.
go back to reference Vellinga A, Bennett K, Murphy AW, Cormican M: Principles of multilevel analysis and its relevance to studies of antimicrobial resistance. J Antimicrob Chemother 2012,67(10):2316-2322. 10.1093/jac/dks237CrossRefPubMed Vellinga A, Bennett K, Murphy AW, Cormican M: Principles of multilevel analysis and its relevance to studies of antimicrobial resistance. J Antimicrob Chemother 2012,67(10):2316-2322. 10.1093/jac/dks237CrossRefPubMed
6.
go back to reference Wolkewitz M, Vonberg R, Grundmann H, Beyersmann J, Gastmeier P, Bärwolff S, Geffers C, Behnke M, Rüden H, Schumacher M: Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 2008, 12: R44. 10.1186/cc6852PubMedCentralCrossRefPubMed Wolkewitz M, Vonberg R, Grundmann H, Beyersmann J, Gastmeier P, Bärwolff S, Geffers C, Behnke M, Rüden H, Schumacher M: Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: application of competing risks models. Crit Care 2008, 12: R44. 10.1186/cc6852PubMedCentralCrossRefPubMed
7.
go back to reference Schumacher M, Allignol A, Beyersmann J, Binder N, Wolkewitz M: Hospital-acquired infections: appropriate statistical treatment is urgently needed. Int J Epidemiol 2013, 42: 1502-1508. 10.1093/ije/dyt111CrossRefPubMed Schumacher M, Allignol A, Beyersmann J, Binder N, Wolkewitz M: Hospital-acquired infections: appropriate statistical treatment is urgently needed. Int J Epidemiol 2013, 42: 1502-1508. 10.1093/ije/dyt111CrossRefPubMed
8.
go back to reference Wolkewitz M, Harbarth S, Beyersmann J: Daily chlorhexidine bathing and hospital-acquired infection. N Engl J Med 2013,368(24):2330.CrossRefPubMed Wolkewitz M, Harbarth S, Beyersmann J: Daily chlorhexidine bathing and hospital-acquired infection. N Engl J Med 2013,368(24):2330.CrossRefPubMed
9.
go back to reference Wolkewitz M, Di Termini S, Cooper B, Meerpohl J, Schumacher M: Paediatric hospital-acquired bacteraemia in developing countries. Lancet 2012,379(9825):1484-1485.CrossRefPubMed Wolkewitz M, Di Termini S, Cooper B, Meerpohl J, Schumacher M: Paediatric hospital-acquired bacteraemia in developing countries. Lancet 2012,379(9825):1484-1485.CrossRefPubMed
10.
go back to reference Liquet B, Timsit JF, Rondeau V: Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units. BMC Med Res Methodol 2012, 12: 79. 10.1186/1471-2288-12-79PubMedCentralCrossRefPubMed Liquet B, Timsit JF, Rondeau V: Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units. BMC Med Res Methodol 2012, 12: 79. 10.1186/1471-2288-12-79PubMedCentralCrossRefPubMed
11.
go back to reference Katsahian S, Boudreau C: Estimating and testing for center effects in competing risks. Stat Med 2011,30(13):1608-1617. 10.1002/sim.4132CrossRefPubMed Katsahian S, Boudreau C: Estimating and testing for center effects in competing risks. Stat Med 2011,30(13):1608-1617. 10.1002/sim.4132CrossRefPubMed
13.
go back to reference Lopez-Pueyo M, Olaechea-Astigarraga P, Palomar-Martinez M, Insausti-Ordenana J, Alvarez-Lerma F, ENVIN-HELICS Study Group: Quality control of the surveillance programme of ICU-acquired infection (ENVIN-HELICS registry) in Spain. J Hosp Inf 2013,84(2):126-31. 10.1016/j.jhin.2013.02.018CrossRef Lopez-Pueyo M, Olaechea-Astigarraga P, Palomar-Martinez M, Insausti-Ordenana J, Alvarez-Lerma F, ENVIN-HELICS Study Group: Quality control of the surveillance programme of ICU-acquired infection (ENVIN-HELICS registry) in Spain. J Hosp Inf 2013,84(2):126-31. 10.1016/j.jhin.2013.02.018CrossRef
14.
go back to reference Rondeau V, Commenges D, Joly P: Maximum penalized likelihood estimation in a gamma-frailty model. Lifetime Data Anal 2003,9(2):139-153. 10.1023/A:1022978802021PubMedCentralCrossRefPubMed Rondeau V, Commenges D, Joly P: Maximum penalized likelihood estimation in a gamma-frailty model. Lifetime Data Anal 2003,9(2):139-153. 10.1023/A:1022978802021PubMedCentralCrossRefPubMed
15.
go back to reference Andersen PK, Geskus RB, de Witte T, Putter H: Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012,41(3):861-870. 10.1093/ije/dyr213PubMedCentralCrossRefPubMed Andersen PK, Geskus RB, de Witte T, Putter H: Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012,41(3):861-870. 10.1093/ije/dyr213PubMedCentralCrossRefPubMed
16.
go back to reference Fine J, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999,94(446):496-509. 10.1080/01621459.1999.10474144CrossRef Fine J, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999,94(446):496-509. 10.1080/01621459.1999.10474144CrossRef
17.
go back to reference Rondeau V, Mazroui Y, Gonzalez JR: frailtypack: an R package for the analysis of correlated survival data with frailty models using penalized likelihood estimation or parametrical estimation. J Stat Softw 2012,47(4):1-28.CrossRef Rondeau V, Mazroui Y, Gonzalez JR: frailtypack: an R package for the analysis of correlated survival data with frailty models using penalized likelihood estimation or parametrical estimation. J Stat Softw 2012,47(4):1-28.CrossRef
18.
go back to reference Hansen S, Schwab F, Behnke M, Carsauw H, Heczko P, Klavs I, Lyytikainen O, Palomar M, Riesenfeld Orn I, Savey A, Szilagyi E, Valinteliene R, Fabry J, Gastmeier P: National influences on catheter-associated bloodstream infection rates: practices among national surveillance networks participating in the European HELICS project. J Hosp Infect 2009, 71: 66-73. 10.1016/j.jhin.2008.07.014CrossRefPubMed Hansen S, Schwab F, Behnke M, Carsauw H, Heczko P, Klavs I, Lyytikainen O, Palomar M, Riesenfeld Orn I, Savey A, Szilagyi E, Valinteliene R, Fabry J, Gastmeier P: National influences on catheter-associated bloodstream infection rates: practices among national surveillance networks participating in the European HELICS project. J Hosp Infect 2009, 71: 66-73. 10.1016/j.jhin.2008.07.014CrossRefPubMed
19.
go back to reference Palomar M, Alvarez-Lerma F, Riera A, Diaz M, Torres F, Agra Y, Larizgoitia I, Goeschel C, Pronovost P: Impact of a national multimodal intervention to prevent catheter-related bloodstream infection in the ICU:the Spanish experience. Crit Care Med 2013,41(10):2364-2372. 10.1097/CCM.0b013e3182923622CrossRefPubMed Palomar M, Alvarez-Lerma F, Riera A, Diaz M, Torres F, Agra Y, Larizgoitia I, Goeschel C, Pronovost P: Impact of a national multimodal intervention to prevent catheter-related bloodstream infection in the ICU:the Spanish experience. Crit Care Med 2013,41(10):2364-2372. 10.1097/CCM.0b013e3182923622CrossRefPubMed
20.
go back to reference Wolkewitz M, Tacconelli E, Schumacher M: Aggressive versus conservative initiation of antibiotics. Lancet Infect Dis 2013,13(5):387-388. 10.1016/S1473-3099(13)70064-1CrossRefPubMed Wolkewitz M, Tacconelli E, Schumacher M: Aggressive versus conservative initiation of antibiotics. Lancet Infect Dis 2013,13(5):387-388. 10.1016/S1473-3099(13)70064-1CrossRefPubMed
21.
go back to reference Aiken AM, Mturi N, Njuguna P, Mohammed S, Berkley JA, Mwangi I, Mwarumba S, Kitsao BS, Lowe BS, Morpeth SC, Hall AJ, Khandawalla I, Scott JA, Ahmed I, Akech S, Makazi AB, Hajj MB, Brent A, Chesaro C, Dayo H, Idro R, Kosgei P, Maitland K, Marsh K, Mwalekwa L, Mwaringa S, Newton C, Ngama M, Pamba A, Peshu N, et al.: Risk and causes of paediatric hospital-acquired bacteraemia in K, ilifi District Hospital, Kenya: a prospective cohort study. Lancet 2011,378(9808):2021-2027. 10.1016/S0140-6736(11)61622-XPubMedCentralCrossRefPubMed Aiken AM, Mturi N, Njuguna P, Mohammed S, Berkley JA, Mwangi I, Mwarumba S, Kitsao BS, Lowe BS, Morpeth SC, Hall AJ, Khandawalla I, Scott JA, Ahmed I, Akech S, Makazi AB, Hajj MB, Brent A, Chesaro C, Dayo H, Idro R, Kosgei P, Maitland K, Marsh K, Mwalekwa L, Mwaringa S, Newton C, Ngama M, Pamba A, Peshu N, et al.: Risk and causes of paediatric hospital-acquired bacteraemia in K, ilifi District Hospital, Kenya: a prospective cohort study. Lancet 2011,378(9808):2021-2027. 10.1016/S0140-6736(11)61622-XPubMedCentralCrossRefPubMed
22.
go back to reference Latouche A, Allignol A, Beyersmann J, Labopin M, Fine JP: A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol 2013,66(6):648-653. 10.1016/j.jclinepi.2012.09.017CrossRefPubMed Latouche A, Allignol A, Beyersmann J, Labopin M, Fine JP: A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol 2013,66(6):648-653. 10.1016/j.jclinepi.2012.09.017CrossRefPubMed
23.
go back to reference Cheng AC, Bass P, Scheinkestel C, Leong T: Public reporting of infection rates as quality indicators. Med J Aust 2011,195(6):326-327. 10.5694/mja11.10778CrossRefPubMed Cheng AC, Bass P, Scheinkestel C, Leong T: Public reporting of infection rates as quality indicators. Med J Aust 2011,195(6):326-327. 10.5694/mja11.10778CrossRefPubMed
24.
go back to reference Gastmeier P, Brauer H, Hauer T, Schumacher M, Daschner F, Ruden H: How many nosocomial infections are missed if identification is restricted to patients with either microbiology reports or antibiotic administration? Infect Control Hosp Epidemiol 1999,20(2):124-127. 10.1086/501600CrossRefPubMed Gastmeier P, Brauer H, Hauer T, Schumacher M, Daschner F, Ruden H: How many nosocomial infections are missed if identification is restricted to patients with either microbiology reports or antibiotic administration? Infect Control Hosp Epidemiol 1999,20(2):124-127. 10.1086/501600CrossRefPubMed
Metadata
Title
Multilevel competing risk models to evaluate the risk of nosocomial infection
Authors
Martin Wolkewitz
Ben S Cooper
Mercedes Palomar-Martinez
Francisco Alvarez-Lerma
Pedro Olaechea-Astigarraga
Adrian G Barnett
Stephan Harbarth
Martin Schumacher
Publication date
01-04-2014
Publisher
BioMed Central
Published in
Critical Care / Issue 2/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13821

Other articles of this Issue 2/2014

Critical Care 2/2014 Go to the issue